▒▒ 인제대학교 약물유전체연구센터 ▒▒

· Kim MJ, Kim H, Cha IJ, Park JS, Shon JH, Liu KH, Shin JG.

High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry.(NRL)

Rapid Commun Mass Spectrom. 2005;19(18):2651-2658 [LINK]

2005-International

· Kim SH, Han J, Seog DH, Chung JY, Kim N, Hong Park Y, Lee SK.

Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression.()

Life Sci. 2005 Jan 28;76(11):1297-306 [LINK]

2005-International

· Cuong DV, Kim N, Joo H, Youm JB, Chung JY, Lee Y, Park WS, Kim E, Park YS, Han J.

Subunit composition of ATP-sensitive potassium channels in mitochondria of rat hearts.()

Mitochondrion. 2005 Apr;5(2):121-33 [LINK]

2005-International

· Braunschweig T, Chung JY, Hewitt SM.

Tissue microarrays: bridging the gap between research and the clinic.()

Expert Rev Proteomics. 2005 Jun;2(3):325-36 [LINK]

2005-International

· Liu KH, Moon JK, Kang SH, Koo S, Lee HS, Kim JH.

Identification of Rat Urinary and Fecal Metabolites of a New Herbicide, Pyribenzoxim()

J. Agric. Food Chem.; 2005; 53(17) pp 6713 - 6717 [LINK]

2005-International

· Shon JH, Yoon YR, Hong WS, Nguyen PM, Lee SS, Choi YG, Cha IJ, Shin JG.

Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism(NRL)

Clin Pharmacol Ther. 2005;78(2):191-201. [LINK]

2005-International

· Cho MJ, Gwak JG, Park SY, Won JJ, Kim DE, Yea SS, Cha IJ, Kim TK, Shin JG, Oh S.

Diclofenac attenuates Wnt/b-catenin signaling in colon cancer cells by activation of NF-kB()

FEBS Letters, 2005, 579/4213~4218 [LINK ]

2005-International

· Lee SS, Kim SY, Kim WY, Thi-Le H, Yoon YR, Yea SS, Shin JG.

MDR1 Genetic Polymorphisms and Comparison of MDR1 Haplotype Profiles in Korean and Vietnameses Populations(NRL)

Ther Drug Monit, 2005; 27(4):531-535. [LINK]

2005-International

· Shon JH, Yoon YR, Kim MJ, Kim KA, Lim YC, Liu KH, Shin DH, Lee CH, Cha IJ, Shin JG.

Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but by CYP2C19 genetic polymorphism(NRL)

Br J Clin Pharmacol, 2005, 59/552~563 [LINK]

2005-International

· Lee SS, Kim KM, Thi-Le H, Yea SS, Cha IJ, Shin JG.

Genetic Polymorphism of CYP2C9 in a Vietnamese Kinh Population(NRL)

Ther Drug Monit, 2005, 27/208~210 [LINK]

2005-International

논문실적

연구실적